NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 6,870.00
+10.00 (0.15%)
Sep 18, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 83.81 billion as of September 18, 2026. Its market cap has decreased by -54.95% in one year.
Market Cap
83.81B
Enterprise Value
45.53B
Revenue
2.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,870.00
ChartMarket Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 83.81B, a decrease of -64.03%. That is a compound annual growth rate of -58.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 83.81B | -67.63% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.64T |
| Celltrion | 40.98T |
| ALTEOGEN | 17.65T |
| Samsung Epis Holdings | 8.12T |
| MedPacto | 93.23B |
| Osang Healthcare Co.,Ltd | 91.60B |
| iNtRON Biotechnology | 87.42B |
| CMG Pharmaceutical | 84.28B |